Filing Details
- Accession Number:
- 0000904454-13-000768
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-07-02 16:55:03
- Reporting Period:
- 2013-07-01
- Filing Date:
- 2013-07-02
- Accepted Time:
- 2013-07-02 16:55:03
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1434868 | Esperion Therapeutics Inc. | ESPR | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1374150 | P L Vii Parters Domain | C/O Domain Associates, Llc One Palmer Square Princeton NJ 08542 | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2013-07-01 | 1,786,012 | $0.00 | 1,786,012 | No | 4 | C | Direct | |
| Common Stock | Acquisiton | 2013-07-01 | 280,923 | $14.00 | 2,066,935 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | C | Direct | |
| No | 4 | P | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Series A Preferred Stock | Disposition | 2013-07-01 | 1,786,012 | $0.00 | 1,786,012 | $0.00 |
| Series A Preferred Stock | Warrant to Purchase Series A Preferred Stock | Disposition | 2013-07-01 | 489,320 | $0.00 | 489,320 | $1.00 |
| Common Stock | Warrant to Purchase Common Stock | Acquisiton | 2013-07-01 | 70,042 | $0.00 | 70,042 | $6.99 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | No | 4 | C | Direct | ||
| 0 | No | 4 | J | Direct | ||
| 70,042 | 2018-02-12 | No | 4 | J | Direct |
Footnotes
- All outstanding shares of Series A Preferred Stock were automatically converted into Common Stock upon the closing of the Issuer's initial public offering (the "IPO"), for no additional consideration.
- Upon the closing of the IPO the Warrants to purchase Series A Preferred Stock automatically converted on a 6.986-for-1 basis into Warrants to purchase Common Stock, and the exercise price automatically adjusted to $6.99 per share, pursuant to the terms of such Warrants. This transaction is reported on Form 4 solely for the purpose of reflecting such changes.
- The Warrant is immediately exercisable.
Billionaire Hedge Funds
